Gritstone bio Inc. (GRTS): Utang marang Ekuitas

Logo korporat perusahaan Gritstone bio (GRTS)

The market price visualization for Gritstone bio, Inc. (GRTS) demonstrates a total debt-to-equity ratio of 4.48. Gritstone bio, Inc. (GRTS) develops personalized cancer vaccines, leveraging the expertise of leading immunologists dedicated to creating innovative medicines. Such research remains independent of economic cycles or inflation, reflecting stable demand. The firm's environmental policy is limited to laboratory safety controls and office recycling.

GRTS: Rasio Total Utang marang Ekuitas Gritstone Bio 04.07.2022 - 02.11.2024

Rincian metrik komprehensif lan analitis Gritstone bio (GRTS)

- rega lan prakiraan konsensus rega:
Bagan rega Gritstone bio Inc.|GRTS - Rata-rata rega prakiraan
- data kapitalisasi bursa:
Nilai pasar Gritstone bio|GRTS - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Gritstone bio|GRTS - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku gritstonebio.com|GRTS - Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Gritstone bio, Inc.|GRTS - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Gritstone bio Inc.|GRTS - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Gritstone bio|GRTS - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan Gritstone bio|Indikator likuiditas cepet gritstonebio.com
- informasi bathi lan kelipatan valuasi:
GRTS - Bathi pungkasan
Analisis fundamental perusahaan:Gritstone bio, Inc., GRTS
Barang utama Gritstone bio Inc.

This indicator measures the ratio of debt to equity, determining the business's degree of financial independence and default risk. By analyzing the debt-to-equity chart, an investor can see the critical dependence of Gritstone bio, Inc. (GRTS) on creditors, which, under the conditions of debt restructuring during bankruptcy, makes any funding for vaccine clinical trials extremely limited and risky.

Pesaing Gritstone bio, Inc. (GRTS)

Utang marang Ekuitas ImmunityBio|Utang marang Modal Immunocore Holdings IMCR|Utang marang Ekuitas Janux Pharma (JANX)|Arcus Corp - Rasio Utang marang Ekuitas|Total Utang marang Modal ZYME (Zymeworks Inc.)|TNGX - Rasio Total Utang marang Ekuitas|IOVA - Utang marang Ekuitas|Utang marang Modal Immatics NV|Xencor Corp (XNCR) - Utang marang Ekuitas|CMPX (Compass Therapeutics Corp) - Utang marang Ekuitas|Utang marang Ekuitas Replimune Group, Inc.|Utang marang Modal lyell.com LYEL|Total Utang marang Modal IPHA|pyxisoncology.com (PYXS) - Rasio Utang marang Modal|Compugen - Rasio Total Utang marang Ekuitas|IO Biotech Inc. (IOBT) - Utang marang Modal|STRO: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi INKT (minktherapeutics.com)|HOWL: Total Utang marang Modal|IMMX - Koefisien Total Utang marang Modal|Utang marang Ekuitas ALX Oncology Holdings|Rasio Total Utang marang Ekuitas cuebiopharma.com (CUE)|Utang marang Ekuitas PDS Biotechnology (PDSB)|Rasio Total Utang marang Ekuitas sonnetbio.com SONN|MAIA Biotechnology, Inc. - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Liminatus Pharma Inc. LIMN|LVTX - Utang marang Ekuitas|NXTC (NextCure Corporation) - Rasio Utang marang Ekuitas|leaptx.com (LPTX) - Utang marang Ekuitas|Utang marang Modal Intensity Therapeutics, Inc. (INTS)|Rasio Total Utang marang Ekuitas SNSE|TOVX - Rasio Utang marang Modal|Rasio Total Utang marang Ekuitas KA (Kineta Bio)|Utang Agregat marang Modal NEXI|Total Utang marang Modal TSBX (Turnstone Biologics Corp.)|Rasio Kabeh Utang marang Dana Pribadi VCNX|Harpoon Therapeutics, Inc. - Total Utang marang Modal